KREBS BIOCHEMICALS & INDUSTRIES
|
The Current P/E Ratio of KREBS BIOCHEMICALS & INDUSTRIES is -6.68.
Share Price | ₹75.9 | May 07,2025 |
Market Cap | ₹163.8 Cr | |
Earnings-TTM | ₹-24.5 Cr | TTM-Standalone Results |
Price/Earnings | -6.68x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of KREBS BIOCHEMICALS & INDUSTRIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹163.8 Cr] as on May 07,2025
(/) Earnings [ ₹-24.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -6.68x ]
Thus, for KREBS BIOCHEMICALS & INDUSTRIES , the investors are currently willing to pay -6.68 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KREBS BIOCHEMICALS & INDUSTRIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KREBS BIOCHEMICALS & INDUSTRIES over the last five years.
Historical PE (Price/Earnings) ratio chart of KREBS BIOCHEMICALS & INDUSTRIES
PE Ratio Performance Analysis for KREBS BIOCHEMICALS & INDUSTRIES
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- KREBS BIOCHEMICALS & INDUSTRIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio peaked in Mar2024 at 0x.
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does KREBS BIOCHEMICALS & INDUSTRIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
KREBS BIOCHEMICALS & INDUSTRIES | -24.52 | -6.68 | 163.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.89 | 423,771.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 76.52 | 158,175.0 |
CIPLA LTD | 5,000.43 | 24.01 | 120,076.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 57.86 | 107,727.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.66 | 95,853.9 |
MANKIND PHARMA LTD | 2,050.73 | 48.97 | 100,426.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.11 | 87,728.5 |
LUPIN LTD | 2,892.10 | 31.79 | 91,953.4 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.22 | 67,274.2 |
ABBOTT INDIA LTD | 1,334.46 | 47.81 | 63,795.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KREBS BIOCHEMICALS & INDUSTRIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -6.68x |
Max industry PE | 76.52x |
Median industry PE | 31.79x |
Average industry PE | 33.92x |
You may also like the below Video Courses